Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva® Advanced Cervical Scan, based on its patented biophotonic technology, announced today it had passed...
MedAlliance has announced the completion of patient enrolment in the PRISTINE clinical trial with SELUTION SLR™ 018 DEB (drug-eluting balloon) for the treatment of patients...
Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create...
The study will look at how intensive non-surgical periodontal therapy and home dental hygiene impact overall health.
Alphabet’s life science subsidiary Verily is teaming up...
The trial is the first study to compare interventional therapy in combination with anticoagulation vs. anticoagulation alone for pulmonary embolism.
A new study using Boston Scientific's EkoSonic...
CartiHeal Ltd, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, which was granted Breakthrough Device...
One of the world’s leading centres in gastroenterology has concluded a clinical trial to investigate the use of a remote-monitoring device and app to...
They will highlight the application of digital cardiac rehabilitation in cardio-oncology.
Queensland-based digital health firm Cardihab and Baker Heart and Diabetes Institute, a medical research...
